J Clin Neurol.  2011 Mar;7(1):31-33. 10.3988/jcn.2011.7.1.31.

Repetitive Nerve Stimulation Test in Amyotrophic Lateral Sclerosis with Predominant Oropharyngeal Manifestations

• Kim JY
• Park KD
• Kim SM
• Sunwoo IN

• KMID: 1452570
• DOI: http://doi.org/10.3988/jcn.2011.7.1.31

Abstract

BACKGROUND AND PURPOSE
Amyotrophic lateral sclerosis (ALS) patients display easy fatigability and abnormal decrements on repetitive nerve stimulation (RNS) test of clinically involved limb muscles, which can result in ALS being misdiagnosed as myasthenia gravis. We retrospectively analyzed the RNS tests of ten ALS patients with only or predominant oropharyngeal symptoms without ocular or facial weakness.
METHODS
RNS tests were performed on the abductor digiti quinti, flexor carpi ulnaris, orbicularis oculi (OO), nasalis and trapezius muscles at low-rate stimulation frequencies of 3 and 5-Hz. Decrements greater than 10% of the compound muscle action potential amplitude on the fifth stimulation compared to the first was regarded as abnormal.
RESULTS
Six patients complained of muscular fatigue or diurnal fluctuation. Among the ten patients, three exhibited abnormal decrements during low-rate stimulation in the facial muscles but not in the limb muscles, two exhibited abnormal decrements in the OO and nasalis muscles, and one exhibited abnormal decrements in the OO muscle.
CONCLUSIONS
These findings show that the facial muscles may be involved in some early oropharyngeal forms of ALS, although facial weakness may not be clinically evident. We confirm herein that abnormal decrement of facial muscles to RNS test cannot make a definite diagnose for myasthenia gravis.

Keyword

amyotrophic lateral sclerosis; repetitive nerve stimulation test; facial muscles

MeSH Terms

Action Potentials
Amyotrophic Lateral Sclerosis
Extremities
Facial Muscles
Humans
Muscle Fatigue
Muscles
Myasthenia Gravis
Retrospective Studies

Reference

1. Mulder DW, Lamber EH, Eaton LM. Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology. 1959. 9:627–631.

2. Denys EH, Norris FH Jr. Amyotrophic lateral sclerosis. Impairment of neuromuscular transmission. Arch Neurol. 1979. 36:202–205.

3. Bernstein LP, Antel JP. Motor neuron disease: decremental responses to repetitive nerve stimulation. Neurology. 1981. 31:204–207.

4. Killian JM, Wilfong AA, Burnett L, Appel SH, Boland D. Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve. 1994. 17:747–754.

5. Wang FC, De Pasqua V, Gérard P, Delwaide PJ. Prognostic value of decremental responses to repetitive nerve stimulation in ALS patients. Neurology. 2001. 57:897–899.

6. Pinto S, de Carvalho M. Amyotrophic lateral sclerosis patients and ocular ptosis. Clin Neurol Neurosurg. 2008. 110:168–170.

7. Restivo DA, Bianconi C, Ravenni R, De Grandis D. ALS and myasthenia: an unusual association in a patient treated with riluzole. Muscle Nerve. 2000. 23:294–295.

8. AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine. Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve. 2001. 24:1239–1247.

9. Bjornskov EK, Dekker NP, Norris FH Jr, Stuart ME. End-plate morphology in amyotrophic lateral sclerosis. Arch Neurol. 1975. 32:711–712.

10. Dupuis L, Loeffler JP. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol. 2009. 9:341–346.

11. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004. 185:232–240.